Phlebological Review
eISSN: 1509-5738
ISSN: 1232-7174
Phlebological Review
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
1/2021
vol. 29
 
Share:
Share:
more
 
 
abstract:
Original paper

Single-centre experience with mechanochemical ablation of insufficient veins with the Flebogrif® catheter in a 36-month follow-up

Marek Iłżecki
1
,
Piotr Terlecki
1
,
Stanisław Przywara
1
,
Tomasz Zubilewicz
1

1.
Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland
Phlebological Review 2021; 29, 1: 32–37
Online publish date: 2021/06/18
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Flebogrif® is the youngest representative of the MOCA treatment group. Its minimally invasive nature and high effectiveness contribute to its popularity. In the presented study, its effectiveness was assessed over a 36-month follow-up.

Material and methods
Observations were conducted over a 36-month period as a prospective study. Two hundred patients meeting the established inclusion criteria were enrolled in the study, including 170 women aged 18 to 87, mean age 56 years, and 30 men, age 23 to 75, mean age 46 years. The obtained numerical data were statistically analysed using tests for variables with nonparametric distribution: Wilcoxon test and Friedman’s ANOVA. The follow-up visits were scheduled as follows: baseline, 1, and 4 weeks and 3, 6, 12, 24, and 36 months. Numerical data were collected based on the assessment validation of venous clinical severity score (VCSS) and visual analogue scale (VAS). Ultrasound evaluation was performed to assess the anatomical effectiveness of the procedure. The safety of the method was assessed in terms of the severity and number of complications.

Results
Based on the VCSS and VAS scale assessment, a statistically significant decrease in the intensity of clinical symptoms was observed both between monitoring visits and in relation to the baseline. One case of deep vein thrombosis (0.5%), 1 prolongated pain, 35 thrombophlebitis, and 28 discolourations (32%) were reported. The 12-month success rate dropped to 92% and remained there until 36 months.

Conclusions
A high success rate of 92% was achieved, which is comparable with other methods currently used in the ablation of insufficient superficial veins. High safety of the method and low number of complications is expressed. Good cosmetic effect. A quick return to previous physical activity is an additional incentive for its use.

keywords:

varicose veins, MOCA, Flebogrif®

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.